| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_151c829c7514890d8640cf4f6abe9e07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e99d9a6ea845cf6c0e6d3d4a7b424c18 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-072 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-071 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 |
| filingDate |
2008-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1467f68e28ffbd960a11e29ac5d58267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca849acbf2348360e69db4a23f34af1a |
| publicationDate |
2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8298575-B2 |
| titleOfInvention |
Two-part capsule to accept pharmaceutical preparations for powder inhalers |
| abstract |
The present invention relates to capsules for holding pharmaceutical preparations for powder inhalers with increased drug safety and capsules for pharmaceutical preparations for powder inhalers with improved adaptation to their use in powder inhalers. The capsules consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but which improve the usability of the filled capsules with regard to their function, their longevity, and/or the geographic location of their use, and are advantageous at various stages from manufacture up to utilization. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8539947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019091422-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571531-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10888675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010275917-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004176391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224705-B2 |
| priorityDate |
1998-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |